TrialVirus research2022

Mouthrinses against SARS-CoV-2 - High antiviral effectivity by membrane disruption in vitro translates to mild effects in a randomized placebo-controlled clinical trial.

Toni Luise Meister et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.